Zymed® Laboratories, a world leader in the development and commercialization of immunochemicals, is a technology-focused, privately owned biotechnology company based in South San Francisco, California, USA. Since its founding nearly two decades ago, the company has been committed to scientific innovation and product excellence.

Zymed offers more than 1500 products for use in immunohistopathology and cell biology research. Zymed's disease marker and cell biology antibodies, detection kits, and immunoassay reagents are used by research and pathology laboratories worldwide. Zymed's exclusive automated ST 5050 immunohistostaining device provides immunohistopathology laboratories with an efficient and cost-effective system for generating results.